Has Taylor Danna received payments from drug or device companies?

Yes. Drug and device makers reported $7,570 in general payments to Taylor Danna across 304 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Taylor Danna did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Taylor Danna come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Taylor Danna

Family · Baton Rouge, LANPI 1306593488

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,628 of the $7,570 with a category attached, or 87.6%. It is spread thinly across 46 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,532 and has fallen 64.7% since, to $894 in 2025. Among family clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,570in general payments, 2019–2025

Across 304 payments — averaging $24.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$2K
AstraZeneca$1K
Johnson & Johnson$707
Daiichi Sankyo Inc.$629
Bristol Myers Squibb$311
Bayer$231
plus $3K from 40 others

What the payments were for

Food & beverage$6,62888%
Education$1272%
Other$81511%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	55	$1,623
AstraZeneca(2 entities)	32	$1,172
Johnson & Johnson(2 entities)	19	$707
Daiichi Sankyo Inc.	23	$629
Bristol Myers Squibb	19	$311
Bayer	9	$231
E.r. Squibb & Sons, L.L.C.	13	$220
Merck	13	$218
AbbVie	9	$188
Beigene USA, Inc.	9	$176
G1 Therapeutics, Inc.	5	$171
Pfizer	9	$154
Ipsen Biopharmaceuticals, Inc	7	$144
Incyte Corporation	7	$141
Eisai Inc.	7	$112
EMD Serono, Inc.	2	$102
Seagen Inc.	7	$100
Tersera Therapeutics LLC	3	$88
Deciphera Pharmaceuticals Inc.	4	$83
Lilly USA, LLC	4	$78
GSK	4	$78
Sanofi	4	$74
Genentech USA, Inc.	3	$64
Amgen	4	$64
Pharmaessentia USA Corporation	2	$62
Array Biopharma Inc	3	$58
Stemline Therapeutics Inc.	3	$51
Takeda Pharmaceuticals U.S.A., Inc.	2	$45
Karyopharm Therapeutics Inc.	2	$38
Servier Pharmaceuticals LLC	2	$37
Gilead	2	$36
Taiho Oncology, Inc.	2	$34
Genmab U.S., Inc.	2	$30
Sobi, Inc	1	$27
Organon	1	$23
Boehringer Ingelheim	1	$22
AVEO Pharmaceuticals, Inc.	1	$22
Mirati Therapeutics, Inc.	1	$20
Cumberland Pharmaceuticals, Inc.	1	$20
Spectrum Pharmaceuticals Inc.	1	$18
Coherus Oncology, Inc.	1	$18
Adaptive Biotechnologies Corporation	1	$18
Boston Scientific	1	$17
Jazz Pharmaceuticals Inc.	1	$17
Puma Biotechnology, Inc.	1	$15
Pharming Healthcare, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,570 in reported general payments places this provider in the 95th percentile of 3,610 family providers in Louisiana.

See all family providers in Louisiana →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Anastrozole	38	$1,184
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	64	$1,157
Ondansetron OdtOndansetron	68	$928
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	21	$636
Lidocaine-PrilocaineLidocaine/Prilocaine	39	$505
Oxycodone Hcl	27	$432
Promethazine Hcl	38	$245
Prednisone	46	$193
Gabapentin	26	$150
Levothyroxine Sodium	17	$104
Zolpidem Tartrate	14	$38
Alprazolam	13	$33

Paid to pharmacies, not to this prescriber.

Other family in Baton Rouge

Elidia DewittBaton Rouge$108K
Ghenet GhebretatiosBaton Rouge$91K
Heather SullivanBaton Rouge$32K
Randee KidderBaton Rouge$30K
Dionne BellBaton Rouge$24K
Jennifer LittleBaton Rouge$21K
Tracy ParkerBaton Rouge$19K
Kristen VillarBaton Rouge$18K
Sharon JacksonBaton Rouge$15K
Gloria MarchandBaton Rouge$14K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →